Lopatnikova Julia A, Vasilyev Filipp F, Alshevskaya Alina A, Sennikov Sergey V
Laboratory of Molecular Immunology, Federal State Budgetary Institution Research Institute of Clinical Immunology, Russian Academy of Medical Sciences Siberian Branch, Novosibirsk, Russia.
J Recept Signal Transduct Res. 2013;33(1):49-55. doi: 10.3109/10799893.2012.756894. Epub 2013 Jan 15.
Tumor necrosis factor (TNF)-α is an inflammatory cytokine, the biological effects of which are mediated by the interaction with specific membrane-bound receptors. To assess TNF-α receptor (TNFR) expression, it is important to estimate both the number of cells that carry these receptors and the number of receptors per cell, because the cell fate depends on the balance between TNFRI and TNFRII signaling.
The aim of the present study was to develop an optimized protocol to estimate the level of expression of membrane-bound TNFRI and TNFRII, using QuantiBRITE PE calibration beads.
The percentage of cells that expressed membrane-bound TNFRI and TNFRII and the mean number of receptors per cell were determined by flow cytometry using PE-labeled antibodies against TNFR. To create a calibration curve and convert cell fluorescence intensity values to absolute numbers of receptors, we used QuantiBRITE PE beads.
CD19(+) B lymphocytes had the least percentage of cells expressing TNFRI and the greatest number of receptor molecules per cell, whereas CD3(+) T lymphocytes had the greatest percentage of cells expressing TNFRII and the lowest density of these receptors. We also established that stimulation of peripheral blood mononuclear cells (PBMCs) with the lipopolysaccharide (LPS) significantly increased the number of TNFRI and TNFRII on CD14(+) monocytes.
Application of the protocol-identified differences in the percentage of cells that expressed TNFRs, as well as the absolute number of receptors per cell, among different subpopulations of PBMCs, and between PBMCs cultured with and without LPS.
肿瘤坏死因子(TNF)-α是一种炎症细胞因子,其生物学效应通过与特定膜结合受体的相互作用介导。为了评估TNF-α受体(TNFR)的表达,估计携带这些受体的细胞数量和每个细胞的受体数量很重要,因为细胞命运取决于TNFRI和TNFRII信号之间的平衡。
本研究的目的是开发一种优化方案,使用QuantiBRITE PE校准微球来估计膜结合TNFRI和TNFRII的表达水平。
使用抗TNFR的PE标记抗体,通过流式细胞术确定表达膜结合TNFRI和TNFRII的细胞百分比以及每个细胞的平均受体数量。为了创建校准曲线并将细胞荧光强度值转换为受体的绝对数量,我们使用了QuantiBRITE PE微球。
CD19(+) B淋巴细胞表达TNFRI的细胞百分比最低,每个细胞的受体分子数量最多,而CD3(+) T淋巴细胞表达TNFRII的细胞百分比最高,这些受体的密度最低。我们还确定,用脂多糖(LPS)刺激外周血单核细胞(PBMC)可显著增加CD14(+)单核细胞上TNFRI和TNFRII的数量。
该方案的应用确定了PBMC不同亚群之间以及在有或没有LPS培养的PBMC之间表达TNFR的细胞百分比以及每个细胞的受体绝对数量的差异。